Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Kimberly Perez"'
Autor:
Yin Zhang, Qiao-Li Wang, Chen Yuan, Alice A. Lee, Ana Babic, Kimmie Ng, Kimberly Perez, Jonathan A. Nowak, Jesper Lagergren, Meir J. Stampfer, Edward L. Giovannucci, Chris Sander, Michael H. Rosenthal, Peter Kraft, Brian M. Wolpin
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-10 (2023)
Abstract Patients with pancreatic ductal adenocarcinoma (PDAC) commonly develop symptoms and signs in the 1–2 years before diagnosis that can result in changes to medications. We investigate recent medication changes and PDAC diagnosis in Nurses’
Externí odkaz:
https://doaj.org/article/0a82e43a21c74225a3aed05fcc0b0536
Autor:
Michael Dougan, James M Cleary, Benjamin Schlechter, Sarah Slater, Kimmie Ng, Brian M Wolpin, Stephanie K Dougan, Anuj K Patel, Nadine J McCleary, Douglas A Rubinson, Lauren K Brais, Peter C Enzinger, Thomas A Abrams, Matthew B Yurgelun, Victoire Cardot-Ruffino, Naima Bollenrucher, Luisa Delius, S Jennifer Wang, Joshua Remland, C Elizabeth Keheler, Keri M Sullivan, Leah H Biller, Kimberly Perez, Harshabad Singh
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 6 (2023)
Background Recombinant granulocyte colony-stimulating factor (G-CSF) is routinely administered for prophylaxis or treatment of chemotherapy-induced neutropenia. Chronic myelopoiesis and granulopoiesis in patients with cancer has been shown to induce
Externí odkaz:
https://doaj.org/article/ffb2b2c1043940efb1756d04927a4861
Autor:
Kathryn A. Mraz, Rachel Hodan, Linda Rodgers-Fouche, Sanjeevani Arora, Francesc Balaguer, Jose G. Guillem, Joanne M. Jeter, Priyanka Kanth, Dan Li, David Liska, Joshua Melson, Kimberly Perez, Charite Ricker, Brian H. Shirts, Eduardo Vilar, Bryson W. Katona, Mev Dominguez-Valentin
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundInternational chemoprevention preferences and approaches in Lynch syndrome (LS) and APC-associated polyposis, including Familial adenomatous polyposis (FAP) and attenuated FAP (AFAP) have not been previously explored.AimTo describe current
Externí odkaz:
https://doaj.org/article/749d660edbd94ab487e05ec3dcad75d6
Autor:
Miguel Acosta, Diana Alcantar, Ivan Alier-Reyes, Carlos Alvarez, Crystal B. Arroyo, David Calderon, David Cardenas, Alejandro R. Castro, Janelle K. Companion, Cristian Constante, Evelyn S. Diaz Telles, Gabriel Fletes, Fatima C. Gama, Celia Garcia Perez, Abigail Garcia, Bailey Garcia, Brandon S. Gutierrez, Karina L. Guzman, Cecilia Hernandez, Jeffery R. Hughey, Monica Ibarra Flores, Adilene I. Jacobo, Brianna Lopez, Norma C. Lopez-De Leon, Jaden D. Martinez, Nayelli Mendoza, Kimberly Perez, Lucio J. Perez, Milagros Perez-Moreno, Caitlin D. Pineda, Elizabeth Pinedo, Julissa G. Portillo, Anais Rico, Laura V. Ruiz, Genevie M. Serrano, Kalia M. Sheldon, Hiroki Terada, Victoria A. Trujillo, Clarissa Vazquez-Ramos, Frank Wang, Dawn Flora, Felipe G. Zavala, Hartnell College Genomics Group
Publikováno v:
Mitochondrial DNA. Part B. Resources, Vol 6, Iss 8, Pp 2373-2375 (2021)
The aphid Chaetosiphon fragaefolii Cockerell, 1901 is an agricultural pest and known vector of strawberry viruses. To better understand its biology and systematics, we performed a genomic analysis on C. fragaefolii collected from Quinalt strawberry p
Externí odkaz:
https://doaj.org/article/2cadc7dbe0d9456cb2456ae4dd207381
Autor:
Rebecca Leylek, Marcela Alcántara-Hernández, Jeffrey M. Granja, Michael Chavez, Kimberly Perez, Oscar R. Diaz, Rui Li, Ansuman T. Satpathy, Howard Y. Chang, Juliana Idoyaga
Publikováno v:
Cell Reports, Vol 32, Iss 12, Pp 108180- (2020)
Summary: Human dendritic cells (DCs) comprise subsets with distinct phenotypic and functional characteristics, but the transcriptional programs that dictate their identity remain elusive. Here, we analyze global chromatin accessibility profiles acros
Externí odkaz:
https://doaj.org/article/81883882618e42bc9e0d0395ae8e2a79
Autor:
Huifeng Niu, Hyunjin Shin, Feng Gao, Jacob Zhang, Brittany Bahamon, Hadi Danaee, Bohuslav Melichar, Russell J. Schilder, Robert L. Coleman, Gerald Falchook, Antoine Adenis, Kian Behbakht, Angela DeMichele, Elizabeth Claire Dees, Kimberly Perez, Ursula Matulonis, Piotr Sawrycki, Dirk Huebner, Jeffrey Ecsedy
Publikováno v:
EBioMedicine, Vol 25, Iss C, Pp 50-57 (2017)
Background: Alisertib (MLN8237) is an investigational, oral, selective Aurora A kinase inhibitor. Aurora A contains two functional single nucleotide polymorphisms (SNPs; codon 31 [F/I] and codon 57 [V/I]) that lead to functional changes. This study i
Externí odkaz:
https://doaj.org/article/24f33928b1e74afda898de75f7832eaf
Autor:
Jorge Castillo, Kimberly Perez
Publikováno v:
Journal of Blood Medicine, Vol 2010, Iss default, Pp 1-8 (2010)
Jorge Castillo, Kimberly PerezThe Warren Alpert Medical School of Brown University, Division of Hematology and Oncology, The Miriam Hospital, Providence, RI , USAAbstract: Chronic lymphocytic leukemia (CLL) is an indolent but incurable disease. Despi
Externí odkaz:
https://doaj.org/article/70e864d2615148f7b13426df238a771f
Autor:
Kimberly Perez, Anna M Chiarella, James M Cleary, Nora Horick, Colin Weekes, Thomas Abrams, Lawrence Blaszkowsky, Peter Enzinger, Marios Giannakis, Lipika Goyal, Jeffrey A Meyerhardt, Douglas Rubinson, Matthew B Yurgelun, Wolfram Goessling, Bruce J Giantonio, Lauren Brais, Victoria Germon, Danielle Stonely, Srivatsan Raghavan, Basil Bakir, Koushik Das, Jason R Pitarresi, Andrew J Aguirre, Michael Needle, Anil K Rustgi, Brian M Wolpin
Publikováno v:
The Oncologist. 28:425-432
Background In preclinical pancreatic ductal adenocarcinoma (PDAC) models, inhibition of hepatocyte growth factor (HGF) signaling using ficlatuzumab, a recombinant humanized anti-HGF antibody, and gemcitabine reduced tumor burden. Methods Patients wit
Autor:
Kimberly Perez, Heather Jacene, Jason L Hornick, Chao Ma, Nuno Vaz, Lauren K Brais, Holly Alexander, William Baddoo, Kristina Astone, Edward D Esplin, John Garcia, Daniel M Halperin, Matthew H Kulke, Jennifer A Chan
Publikováno v:
Endocrine-Related Cancer. 29:533-544
Malignant pheochromocytomas (PHEOs)/paragangliomas (PGLs) are rare tumors for which clinical outcomes remain poorly defined and therapeutic options are limited. Approximately 27% carry pathogenic germline succinate dehydrogenase (SDHx) mutations; the
Autor:
Nitya Raj, Jennifer A. Chan, Stephanie J. Wang, Rahul R. Aggarwal, Susan Calabrese, April DeMore, Lawrence Fong, Jennifer Grabowsky, Thomas A. Hope, Kanti Pallav Kolli, Claire K. Mulvey, Pamela N. Munster, Kimberly Perez, Sippy Punn, Diane Reidy-Lagunes, Sofia Von Fedak, Li Zhang, Emily K. Bergsland
Publikováno v:
British Journal of Cancer.